# Viking Global's Biotech Investments: 23 Startups in Its Portfolio (2026) > The 23 Biotech startups Viking Global has backed, by stage: $4.3B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/viking-global-investors-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Stage not reported 7 - [BridgeBio](https://millionrounds.com/company/bridgebio) - [*AH* Auris Health](https://millionrounds.com/company/auris-health) - [Amylyx Pharmaceuticals](https://millionrounds.com/company/amylyx-pharmaceuticals) - [Xcell Biosciences](https://millionrounds.com/company/xcell-biosciences) - [Solarea Bio](https://millionrounds.com/company/solarea-bio) - [NextGen Jane](https://millionrounds.com/company/nextgen-jane) - [Polaris Genomics](https://millionrounds.com/company/polaris-genomics) ## Series B 7 - [Editas Medicine](https://millionrounds.com/company/editas-medicine) - [*VB* Viela Bio](https://millionrounds.com/company/viela-bio) - [*CT* City Therapeutics](https://millionrounds.com/company/city-therapeutics) - [Abdera Therapeutics](https://millionrounds.com/company/abdera-therapeutics) - [*E* Edios](https://millionrounds.com/company/edios) - [Locus Biosciences](https://millionrounds.com/company/locus-biosciences) - [DermBiont](https://millionrounds.com/company/dermbiont) ## Series C and later 5 - [Ginkgo Bioworks](https://millionrounds.com/company/ginkgo-bioworks) - [*GB* Gingko Bioworks](https://millionrounds.com/company/gingko-bioworks) - [SetPoint Medical](https://millionrounds.com/company/setpoint-medical) - [Deciphera Pharmaceuticals](https://millionrounds.com/company/deciphera-pharmaceuticals) - [*PP* PMV Pharma](https://millionrounds.com/company/pmv-pharma) ## Series A 4 - [Allonnia](https://millionrounds.com/company/allonnia) - [Astarte Medical](https://millionrounds.com/company/astarte-medical) - [Mantra Bio](https://millionrounds.com/company/mantra-bio) - [NextGen](https://millionrounds.com/company/nextgen) ## Segment by segment ### Stage not reported 7 startups · $1.9B raised - [**BridgeBio**](https://millionrounds.com/company/bridgebio) BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers. United States $1.4B - [*AH* **Auris Health**](https://millionrounds.com/company/auris-health) United States $220M - [**Amylyx Pharmaceuticals**](https://millionrounds.com/company/amylyx-pharmaceuticals) Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain. United States $175M - [**Xcell Biosciences**](https://millionrounds.com/company/xcell-biosciences) Xcell Biosciences is a next-generation development and manufacturing platform for enhanced cell therapy performance. United States $14M - [**Solarea Bio**](https://millionrounds.com/company/solarea-bio) Solarea Bio develops microbial therapeutics aimed to treat indications derived from chronic inflammation to aid human health. United States $9.9M - [**NextGen Jane**](https://millionrounds.com/company/nextgen-jane) NextGen Jane is a data-driven women's health company. United States $2.2M - [**Polaris Genomics**](https://millionrounds.com/company/polaris-genomics) Harnessing genomics, we make invisible wounds like PTSD visible. United States $250K ### Series B 7 startups · $1.2B raised - [**Editas Medicine**](https://millionrounds.com/company/editas-medicine) Editas Medicine is a clinical-stage genome editing company that develops genomic medicines for serious diseases. United States $335M - [*VB* **Viela Bio**](https://millionrounds.com/company/viela-bio) Viela Bio is a clinical-stage biotechnology company pioneering and advancing treatments for severe inflammation and autoimmune diseases. United States $325M - [*CT* **City Therapeutics**](https://millionrounds.com/company/city-therapeutics) United States $235M - [**Abdera Therapeutics**](https://millionrounds.com/company/abdera-therapeutics) Abdera Therapeutics is a precision oncology company based in South San Francisco, California, with an additional office in Vancouver, Canada. Canada $142M - [*E* **Edios**](https://millionrounds.com/company/edios) United States $64M - [**Locus Biosciences**](https://millionrounds.com/company/locus-biosciences) Locus Biosciences develops CRISPR-engineered precision antibacterial platform designed to revolutionize the treatment of bacterial disease. United States $54M - [**DermBiont**](https://millionrounds.com/company/dermbiont) DermBiont is a biotech company that develops skin microbiome therapeutics to treat and prevent skin diseases. United States $43M ### Series C and later 5 startups · $1.2B raised - [**Ginkgo Bioworks**](https://millionrounds.com/company/ginkgo-bioworks) Zymergen is now a part of Ginkgo Bioworks! United States $444M - [*GB* **Gingko Bioworks**](https://millionrounds.com/company/gingko-bioworks) United States $275M - [**SetPoint Medical**](https://millionrounds.com/company/setpoint-medical) SetPoint Medical is a commercial-stage medical technology company founded in 2007, focused on developing bioelectronic therapies f United States $256M - [**Deciphera Pharmaceuticals**](https://millionrounds.com/company/deciphera-pharmaceuticals) Deciphera Pharmaceuticals focuses on improving kinase inhibitor treatments. United States $127M - [*PP* **PMV Pharma**](https://millionrounds.com/company/pmv-pharma) United States $62M ### Series A 4 startups · $51M raised - [**Allonnia**](https://millionrounds.com/company/allonnia) Allonnia is a Boston-based bio-ingenuity company founded in 2019, focusing on environmental biotechnology and engineering. United States $20M - [**Astarte Medical**](https://millionrounds.com/company/astarte-medical) Astarte Medical is a clinical intelligence company dedicated to precision medicine for preterm infants and children with medical complexity. United States $13M - [**Mantra Bio**](https://millionrounds.com/company/mantra-bio) Mantra Bio, Inc. United States $9.0M - [**NextGen**](https://millionrounds.com/company/nextgen) 넥스트젠은 크리에이터 수익화 플랫폼입니다. United States $9.0M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Viking Global as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Portfolio map **Viking Global portfolio map** 34 startups · $5.2B](https://millionrounds.com/portfolio-maps/viking-global-investors-portfolio-map)[Co-investors **Who invests with Viking Global** 25 co-investors](https://millionrounds.com/portfolio-maps/viking-global-investors-co-investors)[Sector portfolio **Techstars' AI portfolio** 336 startups · $4.9B](https://millionrounds.com/portfolio-maps/techstars-ai-portfolio)[Sector portfolio **Alumni Ventures' AI portfolio** 302 startups · $36B](https://millionrounds.com/portfolio-maps/us-strategic-tech-fund-an-alumni-ventures-fund-ai-portfolio)[Sector portfolio **Andreessen Horowitz's AI portfolio** 259 startups · $426B](https://millionrounds.com/portfolio-maps/andreessen-horowitz-ai-portfolio)[Sector portfolio **General Catalyst's AI portfolio** 226 startups · $179B](https://millionrounds.com/portfolio-maps/general-catalyst-ai-portfolio) ## Raising from investors like Viking Global? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)